GIRFT Sickle Cell Disease, Thalassaemia and Rare Inherited Anaemia Questionnaire

Closes 19 Dec 2025

Opened 29 Sep 2025

Results expected 19 Dec 2025

Feedback expected 19 Dec 2025

Overview

NHS England’s GIRFT Sickle Cell Disease (SCD) and Thalassaemia Programme is working to deliver data-driven, clinically-led reviews of SCD and Thalassaemia services. The reviews will include Specialist Haemoglobinopathy Teams (SHT) and selected Local Haemoglobinopathy Teams (LHT) in England

The reviews will:

  • Use data and insights to understand how services are delivered and how they compare with similar centres across the country.
  • Highlight examples of good practice, identify challenges, and explore opportunities for improvement.
  • Agree practical actions to support the development and delivery of high-quality SCD and Thalassaemia services.

 

 

Why your views matter

This questionnaire will help us build a clear picture of how your service is delivered. The information provided will inform a data pack that will be shared with you in advance of the review. We ask that the questionnaire is completed by an appropriate member of the SHT or LHT . There are two versions of the questionnaire: one for adult services and one for paediatric services. If you have any queries please contact: england.girft.central@nhs.net.

Audiences

  • Clinicians

Interests

  • NHS England